Heparin-focus on safety.
Golembiewski
Julie
J
Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA.
D016907:Adverse Drug Reaction Reporting Systems; D000925:Anticoagulants / Q000009:adverse effects* / Q000600:supply & distribution; D004340:Drug Contamination / Q000517:prevention & control / Q000706:statistics & numerical data; D004342:Drug Hypersensitivity / Q000209:etiology; D016903:Drug Monitoring; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000009:adverse effects* / Q000600:supply & distribution; D006801:Humans; D009730:Nursing Assessment; D010314:Partial Thromboplastin Time; D016528:Postanesthesia Nursing / Q000379:methods*; D011182:Postoperative Care / Q000379:methods* / Q000451:nursing; D017751:Safety Management / Q000379:methods*; D013921:Thrombocytopenia / Q000139:chemically induced; D014481:United States; D014486:United States Food and Drug Administration; D014914:Whole Blood Coagulation Time
D000925:Anticoagulants; D006493:Heparin